ASKA Pharmaceutical Holdings News

ASKA Pharmaceutical Holdings: Change Report

Oct 16 02:07 ET

ASKA Pharmaceutical Holdings: Tech Doctor and Asuka Pharmaceutical announce the start of joint research on dysmenorrhea under the cooperation of the healthcare application “4MOON”

Sep 24 02:00 ET

ASKA Pharmaceutical Holdings: Change report.

Sep 18 02:03 ET

ASKA Pharmaceutical Holdings: Subsidiary: Announcement of Personnel Changes at Asuka Pharmaceuticals Co., Ltd.

Aug 23 02:00 ET

ASKA Pharmaceutical Holdings: Announcements of individual stocks regarding personnel changes.

Aug 23 02:00 ET

ASKA Pharmaceutical Holdings: Announcements of individual stocks: Approval has been obtained for the manufacture and sale of the oral contraceptive drospirenone in South Korea.

Aug 16 02:00 ET

ASKA Pharmaceutical Holdings: Announcements of individual stocks regarding the completion of payment for the disposal of treasury stock as restricted stock compensation.

Aug 15 02:00 ET

ASKA Pharmaceutical Holdings: Change report.

Aug 13 02:04 ET

ASKA Pharmaceutical Holdings: Supplementary information for the fiscal Q1 financial statement for March 2025.

Aug 5 02:00 ET

ASKA Pharmaceutical Holdings: Short message of Q1 financial results for March 2025 (consolidated, Japanese standard).

Aug 5 02:00 ET

Change Report (Stock Certificates Eligible for Special Provisions, etc.)

Jul 28 22:03 ET

ASKA Pharmaceutical Holdings: Change Report

Jul 19 02:03 ET

ASKA Pharmaceutical Holdings: Announcements of individual stocks regarding disposal of treasury stock as share-based compensation with transfer restrictions.

Jul 16 02:00 ET

ASKA Pharmaceutical Holdings: Extraordinary Report

Jun 28 01:12 ET

ASKA Pharmaceutical Holdings: Report on Corporate Governance, June 28th, 2024.

Jun 28 00:41 ET

ASKA Pharmaceutical Holdings: Announcements of individual stock: Appointment of subsidiary executives and executive officers.

Jun 25 02:00 ET

ASKA Pharmaceutical Holdings: Announcements of individual stocks regarding the job appointment of company executives and executive officers.

Jun 25 02:00 ET

ASKA Pharmaceutical Holdings: Confirmation letter

Jun 25 00:40 ET

ASKA Pharmaceutical Holdings: Internal Control Report - 3rd Period (April 1, 2023 to March 31, 2024)

Jun 25 00:39 ET

ASKA Pharmaceutical Holdings: Security Report - Third Quarter (April 1, 2023 - March 31, 2024)

Jun 25 00:37 ET